Frequently Asked Questions
Does Semaglutide work for weight loss?
Yes. After treating so many patients personally, the documentation speaks for itself. People's recorded weights tend to all go down when taking this treatment regularly, and for more than a few weeks.
Is it safe?
As with any treatment there are side effects. We consult various peer reviewed sources to get an idea of what adverse drug reactions (ADRs) we can expect. The treatment appears to be well tolerated by most patients, and common side effects encountered in practice have been occasional nausea, constipation.
How does it work?
- Mimics GLP-1: Semaglutide mimics the action of the glucagon-like peptide-1 (GLP-1) hormone, which is naturally released after eating.
- Increases Insulin Secretion: It stimulates the pancreas to release insulin when blood sugar levels are high, helping to lower glucose levels.
- Reduces Glucagon Release: It suppresses the release of glucagon, a hormone that raises blood sugar by prompting the liver to release stored glucose.
- Slows Gastric Emptying: It delays the movement of food from the stomach to the intestines, which helps control post-meal blood sugar spikes and promotes a feeling of fullness.
- Appetite Suppression: By acting on the brain's appetite regulation centers, it reduces hunger, aiding in weight loss [1]
How do you take it?
Subcutaneously, which is not the same as intramuscular. It uses a 4mm needle 32guage into one of a few locations of fat on your body. Typically we recommend you alternate sites, and we offer full education on this as needed.
Fee Schedule 7/2025
| Weeks | Dose (mg/week) | Medication Cost | Visit/Consultation | Total |
|---|---|---|---|---|
| Weeks 1-4 | 0.25 | $300.00 | $131.00 | $431.00 |
| Weeks 5-8 | 0.5 | $400.00 | $88.00 | $488.00 |
| Weeks 9-12 | 1.0 | $600.00 | $88.00 | $688.00 |
| Weeks 13-16 | 1.7 | $620.00 | $88.00 | $708.00 |
| Weeks 17-20 | 2.4 | $640.00 | $88.00 | $728.00 |
Email us with any questions: fax@eastcountyim.com
Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- India's Pharmaceutical Industry Faces Quality Concerns Amid Expiration of Semaglutide Patenton November 3, 2025 at 10:12 pm
While Indian Contract Development and Manufacturing Organizations (CDMOs) are strategically positioned to benefit from the growing GLP-1 market, ...
- Study shows semaglutide, tirzepatide and dulaglutide have similar gastrointestinal safety ...on November 3, 2025 at 10:06 pm
... benefits and risks of prescribing these popular medications. More information: Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide ...
- Liver Fibrosis Screening Pathways Perform Similarly in Type 2 Diabetes, but VCTE Improves ...on November 3, 2025 at 7:42 pm
Data Shows Multiple Clinical Benefits Associated With Semaglutide in Treatment of MASH. Yvette C. TerrieMASH/NASH | July 25, 2025. Semaglutide ...
- The Underappreciated Benefits of GLP-1 Receptor Agonists - CU Anschutz newsroomon November 3, 2025 at 4:37 pm
They are prescribed for people living with type 2 diabetes and obesity. Non-brand names include tirzepatide, semaglutide and dulaglutide. View full ...
- Tirzepatide, Semaglutide Reduce Alcohol Use Disorder Risk in Type 2 Diabeteson November 3, 2025 at 3:49 pm
Benefits persisted with at least 6 months of therapy (HR, 0.32; 95% CI, 0.17-0.62) and were observed across weight strata but were most pronounced ...